Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
|Articles|June 10, 2008
IACP sets up branch office at NCPA headquarters
To better ward off blows by the FDA to compounding pharmacists, IACP has established a satellite office at NCPA's headquarters.
Advertisement
The
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
A study of women aged 50 to 69 years found that thrombotic risk varied by route of administration, estradiol dose, and duration of use.
Despite technology fostering a new generation of health care delivery, experts believe rural health solutions should be sought elsewhere.
Medicaid coverage of obesity-labeled GLP-1 receptor agonists may substitute for, rather than simply add to, diabetes-labeled use, a new study finds.
Researchers outline individual peripheral arterial disease burden as well as the most at-risk patient populations and treatment recommendations.
Availability will vary by state, and a pharmacy professor says cost barriers can keep families from getting vaccinated.
Darren Mensch, PharmD, BCPS, BCACP, provides evidence-based nuance regarding the emergence of mRNA vaccine technology and health care’s understanding of it.
Study findings tie continuous glucose monitoring measures to elevated cardiovascular risk in adults without diabetes.
Advertisement
Advertisement
Trending on Drug Topics
1
Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide
2
CDC Opens Orders for COVID-19 Vaccines in Vaccines for Children
3
Pharmacists Are Vital in Complex, Team-Based Treatment of PAD
4
FAQ: Pharmacist Understanding of mRNA Vaccine Technology
5